POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests if adding a biologic drug helps kids with arthritis
Disease control ENROLLING_BY_INVITATIONThis phase 3 trial in Lahore, Pakistan, will enroll 60 children aged 2–16 with newly diagnosed polyarticular juvenile idiopathic arthritis. Half will receive methotrexate alone, and half will receive methotrexate plus etanercept, a biologic drug. Researchers will measure how many…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE3 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stem cell trial for kids with arthritis pulled before it started
Disease control TerminatedThis study was designed to test whether infusions of stem cells from donated fat tissue could safely improve symptoms of juvenile idiopathic arthritis in children aged 2 to 17. The trial was a phase 2, randomized, double-blind, placebo-controlled crossover study, but it was withd…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC